List Title | APhA DrugInfoLine

Focus on Immunizations

SORT BY: Most Recent Most Viewed

February 28, 2017

Two doses of HPV vaccine now recommended for select patients

READ

PREVIEW
The Advisory Committee on Immunization Practices (ACIP) released updated human papillomavirus (HPV) vaccine recommendations that discussed use of a two-dose schedule for the 9-valent vaccine for...
January 24, 2017

Best way to ease immunization-associated pain in infants

READ

PREVIEW
Results of a new randomized trial show that infants given vaccine injections during the first year of life had a reduction in acute pain with consistent use of liposomal lidocaine applied...
October 18, 2016

Investigational herpes zoster vaccine is effective in patients aged 70 years or older

READ

PREVIEW
GlaxoSmithKline’s investigational vaccine was found to be highly effective at preventing shingles and postherpetic neuralgia in patients aged 70 years or older, according to results of a Phase III...
October 11, 2016

9-valent HPV vaccine is safe and well tolerated in girls and boys

READ

PREVIEW
The 9-valent human papillomavirus (9vHPV) vaccine was found to be safe and well tolerated, according to an analysis of seven Phase III studies in patients aged 9 years to 26 years that was...
July 12, 2016

Nasal spray influenza vaccine should not be used during upcoming influenza season

READ

PREVIEW
After an assessment of available data on the effectiveness of the live attenuated influenza vaccine (LAIV) nasal spray, CDC’s Advisory Committee on Immunization Practices (ACIP) voted that this...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.